Literature DB >> 1082492

Participation of the H-2 antigens of tumor cells in their lysis by syngeneic T cells.

J W Schrader, G M Edelman.   

Abstract

Cytotoxic T lymphocytes were generated in vitro against H-2 compatible or syngeneic tumor cells. In vitro cytotoxic activity was inhibited by specific anti-H2 sera, suggesting that H-2 antigens are involved in cell lysis. Two observations directly demonstrated the participation of the H-2 antigens on the tumor cells in their lysis by H-2-compatible T cells. First, coating of the H-2 antigens on the target tumor cell reduced the number of cells lysed on subsequent exposure to cytotoxic T cells. Second, when cytotoxic T cells were activated against an H-2 compatible tumor and assayed against an H-2-incompatible tumor, anti-H-2 serum that could bind to the target cell, but not to the cytotoxic lymphocyte, inhibited lysis. H-2 antigens were also shown to be present on the cytotoxic lymphocytes. Specific antisera reacting with these H-2 antigens, but not those of the target cell, failed to inhibit lysis when small numbers of effector cells were assayed against H-2-incompatible target cells or when effector cells of F1-hybrid origin and bearing two H-2 haplotypes were assayed against a tumor cell of one of the parental strains. These findings suggest that it is the H-2 antigens on the tumor cell and not those on the cytotoxic lymphocytes that are important in cell-mediated lysis of H-2-compatible tumor cells.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1082492      PMCID: PMC2190130          DOI: 10.1084/jem.143.3.601

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  T cell proliferation in the mixed lymphocyte culture does not necessarily result in the generation of cytotoxic T effector cells.

Authors:  M Röllinghoff; K Pfizenmeier; H Trostmann; H Wagner
Journal:  Eur J Immunol       Date:  1975-08       Impact factor: 5.532

2.  Specificity and development of cytotoxic thymus-derived lymphocytes in lymphocytic choriomeningitis.

Authors:  P C Doherty; R M Zinkernagel; I A Ramshaw
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

3.  Anti-theta serum-induced supression of the cellular transfer of tumour-specific immunity to a syngeneic plasma cell tumour.

Authors:  B T Rouse; M Röllinghoff; N L Warner
Journal:  Nat New Biol       Date:  1972-07-26

4.  Isolation of H-2 alloantigens solubilized by the detergent NP-40.

Authors:  B D Schwartz; S G Nathenson
Journal:  J Immunol       Date:  1971-11       Impact factor: 5.422

5.  The effect of capping H-2 antigens on the susceptibility of target cells to humoral and T cell-mediated lysis.

Authors:  M Ekidin; C S Henney
Journal:  Nat New Biol       Date:  1973-11-14

Review 6.  Cell-mediated cytotoxicity, allograft rejection, and tumor immunity.

Authors:  J C Cerottini; K T Brunner
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

7.  Subunit structure, cell surface orientation, and partial amino-acid sequences of murine histocompatibility antigens.

Authors:  R Henning; R J Milner; K Reske; B A Cunningham; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

8.  Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells.

Authors:  U Koszinowski; R Thomssen
Journal:  Eur J Immunol       Date:  1975-04       Impact factor: 5.532

9.  Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro.

Authors:  M S Hirsch; S M Phillips; C Solnik; P H Black; R S Schwartz; C B Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1972-05       Impact factor: 11.205

10.  Mouse cell-mediated lympholysis assay in serum-free and mouse serum-supplemented media: culture conditions and genetic factors.

Authors:  A B Peck; F H Bach
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

View more
  23 in total

1.  Cytolytic thymus-derived lymphocytes specific for allogeneic stimulator cells crossreact with chemically modified syngeneic cells.

Authors: 
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

Review 2.  Role of the major histocompatibility complex in resistance to viral leukemia; its effect on the preleukemic stage of leukemogenesis.

Authors:  P Lonai; E Katz; N Haran-Ghera
Journal:  Springer Semin Immunopathol       Date:  1982

3.  Discrimination between self and nonself.

Authors:  R G Miller
Journal:  Can Med Assoc J       Date:  1980-08-23       Impact factor: 8.262

4.  [Immunopharmacology of corticosteroids].

Authors:  L H Block; W Vetter; W Siegenthaler
Journal:  Klin Wochenschr       Date:  1982-11-15

5.  Cells that express viral antigens but lack H-2 determinants are not lysed by immune thymus-derived lymphocytes but are lysed by other antiviral immune attack mechanisms.

Authors:  R M Zinkernagel; M B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

6.  The cytotoxicity of leukocytes and lymphocytes from patients with rheumatoid arthritis for synovial cells.

Authors:  D A Person; J T Sharp; M D Lidsky
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

7.  Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line.

Authors:  S Kvist; L Ostberg; H Persson; L Philipson; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

Review 8.  Intratumor immunologic heterogeneity.

Authors:  F R Miller
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

9.  Secretion of mediators following T lymphocyte-macrophage interaction is regulated by the major histocompatibility complex.

Authors:  A G Farr; M E Dorf; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

10.  Antigenic specificity of the cytolytic T lymphocyte response to murine sarcoma virus-induced tumors. III. Characterization of cytolytic T lymphocyte clones specific for Moloney leukemia virus-associated cell surface antigens.

Authors:  A Weiss; K T Brunner; H R MacDonald; J C Cerottini
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.